1. Home
  2. TECX vs ORBS Comparison

TECX vs ORBS Comparison

Compare TECX & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.49

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

N/A

Current Price

$0.96

Market Cap

161.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
ORBS
Founded
2019
1966
Country
United States
United States
Employees
60
23
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
161.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
ORBS
Price
$29.49
$0.96
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
172.8K
27.5M
Earning Date
05-07-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$0.74
52 Week High
$35.99
$15.96

Technical Indicators

Market Signals
Indicator
TECX
ORBS
Relative Strength Index (RSI) 48.01 48.42
Support Level $28.31 $0.77
Resistance Level $32.27 $1.29
Average True Range (ATR) 1.55 0.12
MACD -0.35 0.01
Stochastic Oscillator 18.05 29.26

Price Performance

Historical Comparison
TECX
ORBS

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.

Share on Social Networks: